Myeloablative Conditioning with Clofarabine and Busulfan X 4 (CloBu4) Is Well Tolerated, Facilitates Secure Engraftment, and Exhibits Significant Anti-Tumor Activity against Non-Remission Hematologic Malignancies Including AML

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Mineishi, S; Magenau, J; Pawarode, A; Buck, T; Jones, D; Kato, K; Frame, D; Kujawski, L; Erba, HP; Khaled, Y; Peres, EM; Krijanovski, OI; Reddy, P; Kitko, C; Choi, S; Yanik, GA; Braun, T; Ferrara, JLM; Levine, JE

Published Date

  • November 16, 2008

Published In

Volume / Issue

  • 112 / 11

Start / End Page

  • 749 - 749

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 50th Annual Meeting of the American-Society-of-Hematology

Conference Location

  • San Francisco, CA

Conference Start Date

  • December 6, 2008

Conference End Date

  • December 9, 2008